Table 1.
PBX1 metabolic functions across cell types.
| Cell/tissue | PBX1 context | Metabolic pathway | Mechanistic insight | Functional consequence | Disease/context | Reference |
|---|---|---|---|---|---|---|
| Primitive erythroid cells | Pbx1/Meis1 activity | HIF1α signaling | Meis1 induces Hif1a expression; Hif1α directly activates Gata1. Pbx1 cooperates with Meis1 upstream of erythroid specification | Required for primitive erythropoiesis | Hematopoiesis | (97) |
| Mesangial cells | PBX1 activity | Glycolysis/lactate | DNA immune complexes drive glycolysis/lactate-dependent PBX1 lactylation and degradation, reducing P27 expression and promoting G1–S transition | Excessive mesangial cell proliferation | Lupus nephritis | (98) |
| Contralateral unaffected breast epithelium | Increased PBX1 | Lipid metabolism | PBX1 promotes expression of lipid-metabolism genes. | Altered lipid-metabolic transcriptional program | ER-negative breast cancer | (99) |
| Pancreatic cells | Pbx1 deficiency | Glucose homeostasis; insulin secretion | PBX1 cooperates with Ipf1/Pdx1 to maintain pancreatic development and islet function | Decreased insulin secretion; impaired glucose tolerance; diabetes susceptibility | Diabetes mellitus | (103) |
| Astrocytes | PBX1 activity | Glycolysis | PBX1 represses Hk2, reducing L-serine synthesis | Decreased glycolysis; accelerated astrocytic senescence; hyperglycemia and hyperinsulinemia | Chronic stress | (104) |